[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![DividendTalks Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1608087913081839617.png) Dividend Talks on YouTube [@DividendTalks](/creator/twitter/DividendTalks) on x 51.7K followers
Created: 2025-07-07 11:03:25 UTC

4/ Why?

Because GLP-1 drugs like Ozempic and Wegovy are transforming obesity and diabetes treatment.

This is a megatrend, not a fad.

And Novo still commands a 62%+ global market share in the category.

![](https://pbs.twimg.com/media/GvQAQswXwAIv2EP.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942177630955962533/c:line.svg)

**Related Topics**
[novo](/topic/novo)
[wegovy](/topic/wegovy)
[ozempic](/topic/ozempic)
[drugs](/topic/drugs)
[youtube](/topic/youtube)

[Post Link](https://x.com/DividendTalks/status/1942177630955962533)